Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART

Trial Profile

Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART

Discontinued
Phase of Trial: Phase II

Latest Information Update: 16 Apr 2013

At a glance

  • Drugs Rintatolimod (Primary) ; Antiretrovirals
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Apr 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 13 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top